Biomimetic and cell-based nanocarriers - New strategies for brain tumor targeting

last updated: 2022-07-07
ProjectCells4_IDs :: publications list
TitleBiomimetic and cell-based nanocarriers - New strategies for brain tumor targeting
Publication TypeReview Paper
Year of Publication2021
AuthorsMendanha D., Vieira de Castro J., Ferreira H., and Neves N. M.
Abstract Text

In the last two decades no significant advances were achieved in the treatment of the most frequent and malignant types of brain tumors. The main difficulties in achieving progress are related to the incapacity to deliver drugs in therapeutic amounts into the central nervous system and the associated severe side effects. Indeed, to obtain effective treatments, the drugs should be able to cross the intended biological barriers and not being inactivated before reaching the specific therapeutic target. To overcome these challenges the development of synthetic nanocarriers has been widely explored for brain tumor treatment but unfortunately with no clinical translation until date. The use of cell-derived nanocarriers or biomimetic nanocarriers has been studied in the last few years, considering their innate bio-interfacing properties. The ability to carry therapeutic agents and a higher selectivity towards brain tumors would bring new hope for the development of safe and effective treatments. In this review, we explore the biological barriers that need to be crossed for effective delivery in brain tumors, and the types and properties of cell-based nanocarriers (extracellular vesicles and cell-membrane coated nanocarriers) currently under investigation.

JournalJournal of Controlled Release
Date Published2021-09-10
KeywordsBiomimetic carriers, Blood-brain barrier, Cell membrane, Drug delivery, Glioblastoma
RightsembargoedAccess (2 Years)
Peer reviewedyes

Back to top